STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
260
13F, latest reported quarter
What the filings say about CSTM
Insiders, 180 days
-$6.2M net sold
2 buyers · 10 sellers · 0% of sales under a 10b5-1 plan
Constellium insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, CONSTELLIUM SE insiders sold a net $6.2M of stock across 30 Form 4 purchases and sales, with 2 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 32.2% of the 24,873 shares held after it.
7 other insiders sold within 30 days.
260 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Ormerod John sold about $280.1K of CSTM on Jun 4, 2026; 7 other insiders sold within 30 days and 260 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Mar 16, 2026.
The trade is 61.9% of the 16,784 shares held after it.
9 other insiders sold within 30 days.
260 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP CPO Becker Marcus sold about $363.0K of CSTM on May 28, 2026; 9 other insiders sold within 30 days and 260 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 100.0% of the 2,500 shares held after it.
1 other insider bought within 30 days.
260 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Soultz Bradley Lee bought about $84.6K of CSTM on May 14, 2026, the largest insider purchase at the company on our record; 1 other insider bought within 30 days and 260 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 30.7% of the 15,375 shares held after it.
9 other insiders sold within 30 days.
260 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP Chief Innovation Officer Jarrett Martin sold about $157.8K of CSTM on May 14, 2026; 9 other insiders sold within 30 days and 260 funds added in the latest 13F quarter.
30 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CSTM planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
CSTM mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Inspire Fidelis Multi Factor ETF
$2.6M position · as of 2026-05-31
1.3%
Knights of Columbus Small Cap Equity Fund
$2.6M position · as of 2026-07-31
1.2%
WESTWOOD QUALITY SMALLCAP FUND
$9.1M position · as of 2026-07-31
1.0%
SIMT Multi-Strategy Alternatives Fund
$2.2M position · as of 2026-06-30
0.9%
Timothy Plan Small Cap Value Fund
$1.6M position · as of 2026-06-30
0.9%
NORTH SQUARE DYNAMIC SMALL CAP FUND
$5.9M position · as of 2026-05-31
0.8%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Jean-Marc Germain
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$30.2M
$23.4M
$3.3M
+5%
+24%
2024
$8.9M
-$5.3M
$2.2M
-43%
+10%
2023
$10.0M
$23.0M
$2.8M
+11%
+10%
2022
$8.9M
-$3.4M
$2.6M
-34%
-7%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $6.2M sold by insiders over 180 days, 260 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$8.9B
four quarters, 2025-04-01 to 2026-03-31
Revenue, TTM CSTM
FY Dec 2025
$8.4B
FY Dec 2024
$7.3B
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
$2.5B
Dec 2025
$2.2B
Sep 2025
$2.2B
Jun 2025
$2.1B
Mar 2025
$2.0B
Dec 2024
$1.7B
Sep 2024
$1.8B
Jun 2024
$1.9B
At each fiscal year end
Single quarter
Net margin, TTM
+4.9%
net income over revenue, 2025-04-01 to 2026-03-31
Net margin, TTM CSTM
FY Dec 2025
+3.2%
FY Dec 2024
+0.8%
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
+8.1%
Dec 2025
+5.1%
Sep 2025
+4.1%
Jun 2025
+1.7%
Mar 2025
+1.9%
Dec 2024
-2.8%
Sep 2024
+0.4%
Jun 2024
+3.9%
At each fiscal year end
Single quarter
Free cash flow, TTM
$171.0M
operating cash flow minus capex, 2025-04-01 to 2026-03-31
Free cash flow, TTM CSTM
FY Dec 2025
$159.0M
FY Dec 2024
-$112.0M
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
$1.0M
Dec 2025
$109.0M
Sep 2025
$24.0M
Jun 2025
$37.0M
Mar 2025
-$11.0M
Dec 2024
-$90.0M
Sep 2024
-$39.0M
Jun 2024
$54.0M
At each fiscal year end
Single quarter
Debt to equity
1.76x
long-term 2026-03-31 plus current 2026-03-31; equity 2026-03-31
Debt to equity CSTM
FY Dec 2025
2.04x
FY Dec 2024
2.72x
FY Dec 2023
2.69x
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
1.76x
Dec 2025
2.04x
Sep 2025
2.38x
Jun 2025
2.60x
Mar 2025
2.61x
Dec 2024
2.72x
Sep 2024
2.40x
Jun 2024
2.42x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.26x
TTM operating cash flow over long-term 2026-03-31 plus current 2026-03-31
Cash flow to debt CSTM
FY Dec 2025
0.25x
FY Dec 2024
0.16x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
0.26x
Dec 2025
0.25x
Sep 2025
0.17x
Jun 2025
0.15x
Mar 2025
0.17x
Dec 2024
0.16x
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+46.7%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on equity CSTM
FY Dec 2025
+32.9%
FY Dec 2024
+7.9%
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
+46.7%
Dec 2025
+32.9%
Sep 2025
+13.7%
Jun 2025
+4.1%
Mar 2025
+9.6%
Dec 2024
+7.9%
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+7.9%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on assets CSTM
FY Dec 2025
+5.4%
FY Dec 2024
+1.2%
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
+7.9%
Dec 2025
+5.4%
Sep 2025
+2.1%
Jun 2025
+0.6%
Mar 2025
+1.4%
Dec 2024
+1.2%
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital CSTM
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed CSTM
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
7.60x
close 2026-10-26 over four quarters of diluted EPS, 2025-04-01 to 2026-03-31
P/E, trailing CSTM
FY Dec 2025
9.82x
FY Dec 2024
27.03x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
7.98x
Dec 2025
9.82x
Sep 2025
18.37x
Jun 2025
55.42x
Mar 2025
20.18x
Dec 2024
27.03x
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$5.0B
market value at close 2026-10-26 on 2026-03-31 shares, plus long-term 2026-03-31 plus current 2026-03-31, minus cash 2026-03-31
Enterprise value CSTM
FY Dec 2025
$4.4B
FY Dec 2024
$3.3B
FY Dec 2023
$4.6B
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
$5.2B
Dec 2025
$4.4B
Sep 2025
$3.9B
Jun 2025
$3.7B
Mar 2025
$3.3B
Dec 2024
$3.3B
Sep 2024
$4.1B
Jun 2024
$4.5B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+5.4%
TTM free cash flow over market value at close 2026-10-26
FCF yield CSTM
FY Dec 2025
+6.1%
FY Dec 2024
-7.6%
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
+5.1%
Dec 2025
+6.1%
Sep 2025
-2.0%
Jun 2025
-5.5%
Mar 2025
-6.0%
Dec 2024
-7.6%
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.01x
P/E over trailing EPS growth of 516%: four quarters to 2026-03-31 against the four to 2025-03-31
PEG, trailing CSTM
FY Dec 2025
0.02x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
0.02x
Dec 2025
0.02x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CSTM ranks highest on profitability (88th percentile) and institutional and government (84th), and lowest on financial health (35th), among Mining & Metals peers.
Profitability
88
Inputs
Return on equity+46.7% · 97 pct, sector of 89
Return on assets+7.9% · 80 pct, sector of 114
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
35
Inputs
Debt to equity1.76x · 3 pct, sector of 80
Cash flow to debt0.26x · 68 pct, sector of 75
Growth
70
Inputs
Revenue growth, YoY+15.2% · 70 pct, sector of 81
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
44
Inputs
Net Form 4 buying (codes P and S), 180d-$6.2M · 18 pct, sector of 69
Insider buyers, 180d2 · 70 pct, sector of 70
Institutional and government
84
Inputs
Funds adding, latest quarter260 · 84 pct, sector of 152
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
56
Inputs
Short interest, % of float+5.1% · 32 pct, sector of 252
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 47
New text in Risk Factors, latest 10-K+17.0% · 35 pct, sector of 76
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CSTM filings, in plain words
Are Constellium insiders buying or selling CSTM?
In the 180 days to 2026-10-28, Constellium insiders were net sellers, a net $6.2M: $166.4K of purchases and $6.4M of sales reported on Form 4, by 2 buyers and 10 sellers.
Read the full summary
In the 180 days to 2026-10-28, Constellium insiders were net sellers of CSTM, a net $6.2M across purchases and sales reported on Form 4 by 2 buyers and 10 sellers. Sales outweighed purchases more than tenfold by value. None of the 11 insider sales was flagged as made under a Rule 10b5-1 plan. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.